Ipsos: For health reasons, Didier Truchot resigns as Chairman of the Board of Directors of Ipsos. The Board of Ipsos appoints Laurence Stoclet as Chair of the Board.

Core Viewpoint - Didier Truchot resigns as Chairman of the Board of Directors of Ipsos due to health issues, specifically digestive tract cancer, effective February 28, 2026. Laurence Stoclet has been appointed as the new Chair of the Board [1][2]. Group 1: Leadership Changes - Didier Truchot will remain involved with Ipsos as a director and main shareholder after his resignation [2]. - Laurence Stoclet, who has been with Ipsos since 1998 and held various executive roles, will assume the position of Chair on March 1, 2026 [3][7]. - Anne-Marie Couderc has been appointed as Lead Independent Director to strengthen governance [4]. Group 2: Background of Laurence Stoclet - Laurence Stoclet has extensive experience in managing international operations and technology platforms, having served as Chief Financial Officer and Deputy Chief Executive Officer at Ipsos [7][8]. - She oversaw over 100 acquisitions and integration plans, contributing to Ipsos' leadership in the market, which operates in 90 countries [8]. - Stoclet has a strong financial background, including previous roles at Goldman Sachs and Arthur Andersen, and holds an MBA in Banking and Finance [9][12]. Group 3: Company Outlook - Didier Truchot expressed confidence in the company's ability to leverage new technologies, particularly artificial intelligence, under the leadership of Jean Laurent Poitou, the new CEO [5]. - Ipsos is recognized as one of the largest market research companies globally, employing nearly 20,000 people and operating in 90 markets [14].